QMS Medical Allied Services Limited

About

QMS Medical Allied Services Limited distributes medical and healthcare devices in India. The company also manufactures and sells glucometers, pulse oximeters, IR thermometers, BP monitors, anatomy sets, neurology kits, orthopedic aids, and weighing scales, etc.; and operates QMSMEDS, an e-commerce platform that sells healthcare devices of various brands. In addition, the company provides diagnostic and patient management services, including ambulatory blood pressure tracking, continuous blood glucose and blood pressure/glucose monitoring, tonometry, and HbA1C services. Further, it offers Educamedics, which provides customized scientific content in the form of conferences, online courses, webinars, recorded lectures, and others. Additionally, the company offers chemical and chemical products, pharmaceuticals, and medicinal chemical and botanical products. QMS Medical Allied Services Limited was founded in 1994 and is based in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap307 Cr

P/E28.60

Div Yield0.31 %

Book Value₹53.90

52w High₹165.00

52w Low₹69.00

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Mar 2024	Dec 2023
Sales	56.87	44.42	37.26	44.70	46.50	44.58	43.87	37.20	32.29	35.24
Expenses	48.56	38.50	30.51	37.78	39.96	38.21	36.93	29.96	28.34	30.40
Operating Profit	8.31	5.92	6.75	6.92	6.54	6.37	6.94	7.24	3.95	4.84
OPM %	14.61	13.33	18.12	15.48	14.06	14.29	15.82	19.46	12.23	13.73
Other Income	0.42	0.22	0.30	0.22	0.32	1.09	0.19	0.33	0.11	0.15
Depreciation	1.47	1.39	1.02	0.94	0.93	1.36	0.86	0.84	0.88	0.88
Interest	1.71	2.08	1.75	1.36	1.44	1.41	1.31	1.07	0.99	0.81
Profit before tax	5.55	2.67	4.28	4.84	4.49	4.69	4.96	5.66	2.19	3.30
Tax %	28.65	29.21	25.70	26.24	29.62	23.24	30.24	25.27	29.68	25.76
Net Profit	3.96	1.88	3.17	3.58	3.16	3.60	3.47	4.23	1.54	2.44
EPS in Rs	1.89	0.82	1.24	1.61	1.52	1.73	1.51	1.78	0.80	1.26

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024
Sales	173.00	156.00	122.00
Expenses	146.00	130.00	104.00
Operating Profit	27.00	25.00	18.00
OPM %	15.00	16.00	15.00
Other Income	1.00	2.00	0.00
Interest	7.00	5.00	3.00
Depreciation	5.00	4.00	3.00
Profit before tax	16.00	19.00	12.00
Tax %	28.00	27.00	26.00
Net Profit	12.00	14.00	9.00
EPS in Rs	5.21	6.26	4.66
Dividend Payout %	10.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Equity Capital	19.00	18.00	18.00
Reserves	85.00	72.00	61.00
Borrowings	68.00	60.00	35.00
Other Liabilities	41.00	40.00	22.00
Total Liabilities	213.00	190.00	135.00
Fixed Assets	57.00	53.00	24.00
CWIP	0.00	3.00	2.00
Investments	5.00	3.00	2.00
Other Assets	150.00	131.00	108.00
Total Assets	213.00	190.00	135.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Cash from Operating Activity	19.00	20.00	1.00
Cash from Investing Activity	-20.00	-45.00	-3.00
Cash from Financing Activity	1.00	26.00	0.00
Net Cash Flow	0.00	1.00	-1.00
Free Cash Flow	19.00	20.00	1.00
CFO/OP %	91.00	101.00	26.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024
Debtor Days	142.00	101.00	124.00
Inventory Days	181.00	176.00	172.00
Days Payable	73.00	76.00	90.00
Cash Conversion Cycle	250.00	202.00	205.00
Working Capital Days	105.00	100.00	148.00
ROCE %	13.00	17.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Sep 2025	Jun 2025	Mar 2025	Sep 2024	Mar 2024	Sep 2023	Mar 2023	Dec 2022
Promoters	68.11	68.11	68.11	73.67	73.67	73.67	73.67	73.67	73.67	73.67
FIIs	0.00	0.00	0.01	0.01	0.01	0.01	0.01	1.02	1.21	0.71
DIIs	1.59	1.59	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public	30.30	30.30	30.28	26.33	26.33	26.33	26.33	25.32	25.12	25.62
No. of Shareholders	1,554	1,499	1,564	1,489	1,519	1,695	1,586	1,213	1,043	925

Corporate Actions

No corporate actions recorded.

Announcements

5 filings

Appointment
03 Sep 2026 3 Sep - Board appointed Pranav Badheka as independent director; noted material RPT, AGM on September 30, 2026.
Outcome of Board Meeting
03 Sep 2026 3 Sep - Board appointed Pranav Badheka as independent director; approved material related party transaction and 9th AGM notice.
Press Release
27 Aug 2026 27 Aug - QMS signs five-year exclusive India distribution deal with HEINE Optotechnik from 1 January 2027.
Analysts/Institutional Investor Meet/Con. Call Updates
21 Aug 2026 21 Aug - Q1 FY27 earnings call: revenue ₹56.9 crore, EBITDA ₹8.3 crore, PAT ₹4 crore; guidance maintained.
General Updates
19 Aug 2026 19 Aug - QMS Medical Allied Services received CyberVadis Gold certification for 2026, valid until 17 August 2027.

Annual Reports

Conference Calls

Back to all stocks